Desmoglein 3 as a prognostic indicator in lung cancer

被引：0
|
作者：
Fukuoka, J
Dracheva, T
Shih, J
Hewitt, S
Shilo, K
Franks, T
Travis, W
Jen, J
机构：
[1] Toyama Med & Pharmaceut Univ Hosp, Dept Pathol, Toyama, Japan
[2] NCI, Lab Populat Genet, Toyama, Japan
[3] NCI, Biometr Res Branch, Toyama, Japan
[4] AFIP, Dept Pulm & Mediastinal Pathol, Toyama, Japan
[5] NCI, Lab Pathol, Toyama, Japan
[6] Mem Sloan Kettering Canc Ctr, Dept Pathol, Toyama, Japan
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80341-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [1] Desmoglein 3 as a prognostic factor in lung cancer
    Fukuoka, Junya
    Dracheva, Tatiana
    Shih, Joanna H.
    Hewitt, Stephen M.
    Fujii, Takashi
    Kishor, Aparna
    Mann, Felecia
    Shilo, Konstantin
    Franks, Teri J.
    Travis, William D.
    Jen, Jin
    HUMAN PATHOLOGY, 2007, 38 (02) : 276 - 283
  • [2] Lack of desmoglein 2 is an indicator of cancer progression and a poor prognostic factor in stage 1 non-small cell lung cancer
    Kamatani, H.
    Kumagai, N.
    Tanaka, T.
    Kawamura, S.
    Hewitt, S. M.
    Franks, T. J.
    Travis, W. D.
    Jen, J.
    Fukuoka, J.
    LABORATORY INVESTIGATION, 2007, 87 : 324A - 324A
  • [3] Lack of desmoglein 2 is an indicator of cancer progression and a poor prognostic factor in stage 1 non-small cell lung cancer
    Kamatani, H.
    Kumagai, N.
    Tanaka, T.
    Kawamura, S.
    Hewitt, S. M.
    Franks, T. J.
    Travis, W. D.
    Jen, J.
    Fukuoka, J.
    MODERN PATHOLOGY, 2007, 20 : 324A - 324A
  • [4] Significance of the Glasgow Prognostic Score as a prognostic indicator for lung cancer surgery
    Kawashima, Mitsuaki
    Murakawa, Tomohiro
    Shinozaki, Tomohiro
    Ichinose, Junji
    Hino, Haruaki
    Konoeda, Chihiro
    Tsuchiya, Takehiro
    Murayama, Tomonori
    Nagayama, Kazuhiro
    Nitadori, Jun-ichi
    Anraku, Masaki
    Nakajima, Jun
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2015, 21 (05) : 637 - 643
  • [5] Thrombocytosis as a useful prognostic indicator in patients with lung cancer
    Aoe, K
    Hiraki, A
    Ueoka, H
    Kiura, K
    Tabata, M
    Tanaka, M
    Tanimoto, M
    RESPIRATION, 2004, 71 (02) : 170 - 173
  • [6] Can DNA methylation be used as a prognostic indicator in lung cancer?
    Buckingham, Lela
    Bonomi, Philip
    LUNG CANCER MANAGEMENT, 2013, 2 (01) : 9 - 12
  • [7] Prognostic Significance of Desmoglein 2 and Desmoglein 3 in Esophageal Squamous Cell Carcinoma
    Fang, Wang-Kai
    Gu, Wei
    Liao, Lian-Di
    Chen, Bo
    Wu, Zhi-Yong
    Wu, Jian-Yi
    Shen, Jian
    Xu, Li-Yan
    Li, En-Min
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (02) : 871 - 876
  • [8] ɤ-glutamyl hydroxymethyl rhodamine green fluorescence as a prognostic indicator for lung cancer
    Shun Kawashima
    Takafusa Yoshioka
    Haruaki Hino
    Kentaro Kitano
    Kazuhiro Nagayama
    Masaaki Sato
    Ryosuke Kojima
    Mako Kamiya
    Yasuteru Urano
    Jun Nakajima
    General Thoracic and Cardiovascular Surgery, 2020, 68 : 1418 - 1424
  • [9] Glycoprotein nonmetastatic B as a prognostic indicator in small cell lung cancer
    Li, Ying-Na
    Zhang, Lin
    Li, Xiu-Li
    Cui, Da-Jiang
    Zheng, Hua-Dong
    Yang, Shuan-Ying
    Yang, Wei-Lin
    APMIS, 2014, 122 (02) : 140 - 146
  • [10] LUNG-CANCER PLOIDY - A BETTER PROGNOSTIC INDICATOR THAN HISTOLOGY
    ZIMMERMAN, PV
    JOHNSTON, NG
    HAWSON, GAT
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1988, 18 (03): : 549 - 549
12345